Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ: KMTS · Real-Time Price · USD
21.66
-0.57 (-2.56%)
At close: Apr 28, 2026, 4:00 PM EDT
21.66
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
KMTS Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for KMTS stock have an average target of 26.75, with a low estimate of 17 and a high estimate of 32. The average target predicts an increase of 23.50% from the current stock price of 21.66.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for KMTS stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold Maintains $22 → $17 | Hold | Maintains | $22 → $17 | -21.51% | Apr 9, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +47.74% | Apr 7, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +47.74% | Mar 25, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +47.74% | Mar 18, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $22 → $25 | Hold | Maintains | $22 → $25 | +15.42% | Dec 15, 2025 |
Financial Forecast
Revenue This Year
94.83M
from 59.82M
Increased by 58.54%
Revenue Next Year
94.83M
from 94.83M
Decreased by -0.00%
EPS This Year
-2.38
from -5.13
EPS Next Year
-2.40
from -2.38
Revenue Forecast
| Revenue | 2026 | 2026 | 2027 | 2027 | 2028 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|
| High | 97.8M | 97.8M | |||||
| Avg | 94.8M | 94.8M | |||||
| Low | 91.0M | 91.0M |
Revenue Growth
| Revenue Growth | 2026 | 2026 | 2027 | 2027 | 2028 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|
| High | 63.4% | 3.1% | |||||
| Avg | 58.5% | -0.0% | |||||
| Low | 52.1% | -4.1% |
EPS Forecast
| EPS | 2026 | 2026 | 2027 | 2027 | 2028 | 2028 |
|---|---|---|---|---|---|---|
| High | -2.42 | -2.42 | ||||
| Avg | -2.38 | -2.40 | ||||
| Low | -2.31 | -2.34 |
EPS Growth
| EPS Growth | 2026 | 2026 | 2027 | 2027 | 2028 | 2028 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.